...
首页> 外文期刊>Journal of Radioanalytical and Nuclear Chemistry: An International Journal Dealing with All Aspects and Applications of Nuclear Chemistry >Reactor production of ~(32)P for medical applications: an assessment of ~(32)S(n,p)~(32)P and ~(31)P(n,γ)~(32)P methods
【24h】

Reactor production of ~(32)P for medical applications: an assessment of ~(32)S(n,p)~(32)P and ~(31)P(n,γ)~(32)P methods

机译:医疗应用〜(32)P的反应堆生产:〜(32)S(n,p)〜(32)P和〜(31)P(n,γ)〜(32)P方法的评估

获取原文
获取原文并翻译 | 示例
           

摘要

The article describes a comparative study carried out on the reactor production of ~(32)P by two different processes, namely, ~(32)S(n,p)~(32)P and ~(31)P(n,γ)~(32)P with a view to determine the merits and bottlenecks of each method and assess the usefulness of ~(32)P obtained from each of the processes. In a typical batch, 250 g of elemental sulfur when irradiated at a fast neutron flux of ~8 × 10~(11) n cm~(-2) s~(-1) for 60 days, after chemical processing provided about 150 GBq(4.05Ci) of ~(32)P having specific activity of 200TBq(5500Ci)/mmole. On the other hand, irradiation of 0.35 g of red phosphorus at a fast neutron flux of ~7.5 × 10~(13) n cm~(-2) s~(-1) for a period of 60 days gave 75 GBq(2.02Ci) of ~(32)P of specific activity 7 GBq(190mCi)/ mol~(-1). While the specific activity of ~(32)P obtained from ~(32)S(n,p)~(32)P is superior to that obtained from the ~(3l)P(n,γ)~(32)P process, the requirement of elaborate target processing steps involving distillation and purification emerged as a deterrent that limits its widespread adaptability. Both the production routes offer ~(32)P of acceptable quality amenable for medical applications although their specific activity differs.
机译:本文介绍了通过两种不同的过程〜(32)S(n,p)〜(32)P和〜(31)P(n,γ)对〜(32)P生产反应堆进行的比较研究。 )〜(32)P,以确定每种方法的优缺点,并评估从每个过程获得的〜(32)P的有用性。在典型的批次中,经过化学处理后,在以〜8×10〜(11)n cm〜(-2)s〜(-1)的快中子通量辐照60天后,辐射了250 g元素硫,提供了约150 GBq 〜(32)P的(4.05Ci)具有200TBq(5500Ci)/ mmol的比活。另一方面,以〜7.5×10〜(13)n cm〜(-2)s〜(-1)的快中子通量照射0.35 g的红磷60天,得到75 GBq(2.02)比活度〜(32)P的Ci)为7 GBq(190mCi)/ mol〜(-1)。从〜(32)S(n,p)〜(32)P获得的〜(32)P的比活度优于从〜(3l)P(n,γ)〜(32)P过程获得的比活度因此,涉及蒸馏和提纯的精细目标处理步骤的要求作为一种威慑力量出现,限制了其广泛的适应性。两种生产途径均提供〜(32)P的可接受质量,适合医疗应用,尽管它们的比活不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号